EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity

Laura van Lieshout iD, Stacy Ota, Annie Adusei, Eli Wiberg, Katrina Costa-Grant, Dimpal Lata, Serena Dollive, Marissa Stanvick, Ifeyinwa Iwuchukwu, Diane Golebiowski, Jin Yin

Human Gene Therapy · 2024-09 · 35 (17-18) · 767-776

DOI: 10.1089/hum.2024.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy, online erschienen am 13.09.2024. Verfasst von Laura van Lieshout und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA. Hauptthemen laut MEDLINE: Dependovirus, Plasmids, Genetic Vectors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of a helper plasmid to replace adenovirus infection for adeno-associated virus (AAV) manufacturing has been common practice for decades. Adenovirus E4, E2a, and VA RNA genes are sufficient to support efficient AAV replication. In an effort to ensure that all transfected DNA has a functional role in AAV production, deletions were introduced to the E4 and E2a genes to determine if any portions were dispensable. Although a 900 bp deletion in the E2a intron did not have an impact, the removal of open reading frames (orf) 1–4 from the E4 gene resulted in a doubling of AAV productivity. The E4Δorf1-4 deletion was associated with a reduction in E4orf6 transcripts, along with an increase in Rep and Cap transcripts and protein levels, which corresponded to increased AAV productivity in crude lysate. The final product of these studies was a helper plasmid, termed OXB-Helper_3, that is >3.4 kb smaller than the original control plasmid and resulted in ∼2× improvement in vector genome productivity across multiple capsid serotypes, genome designs, and transfection platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusPlasmidsGenetic VectorsHumansVirus ReplicationSequence DeletionAdenovirus E4 ProteinsHEK293 CellsOpen Reading FramesTransfectionHelper Viruses

Stichwörter der Autor:innen

AAVDBPE4orf6adenovirushelper plasmid

Substanzen

Adenovirus E4 Proteins

Autor:innen und Institutionen

  • Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA.

ORCID-Profile: Laura van Lieshout

Zitieren

APA

van Lieshout, L., Ota, S., Adusei, A., Wiberg, E., Costa-Grant, K., Lata, D., Dollive, S., Stanvick, M., Iwuchukwu, I., Golebiowski, D., & Yin, J. (2024). An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity. Human Gene Therapy, 35(17-18), 767-776. https://doi.org/10.1089/hum.2024.059

Vancouver

van Lieshout L, Ota S, Adusei A, Wiberg E, Costa-Grant K, Lata D, et al. An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity. Human Gene Therapy. 2024;35(17-18):767-776. doi:10.1089/hum.2024.059

BibTeX
@article{vanLieshout2024,
  author = {van Lieshout, Laura and Ota, Stacy and Adusei, Annie and Wiberg, Eli and Costa-Grant, Katrina and Lata, Dimpal and Dollive, Serena and Stanvick, Marissa and Iwuchukwu, Ifeyinwa and Golebiowski, Diane and Yin, Jin},
  title = {An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity},
  journal = {Human Gene Therapy},
  year = {2024},
  volume = {35},
  number = {17-18},
  pages = {767--776},
  doi = {10.1089/hum.2024.059}
}
Kostenlos starten →